• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度私营部门结核病护理提供者对新冠疫情第一波的适应情况。

Adaptations to the first wave of the COVID-19 pandemic by private sector tuberculosis care providers in India.

作者信息

Mannan Shamim, Oga-Omenka Charity, Soman ThekkePurakkal Akhil, Huria Lavanya, Kalra Aakshi, Gandhi Ravdeep, Kapoor Tunisha, Gunawardena Nathali, Raj Shekhar, Kaur Manjot, Sassi Angelina, Pande Tripti, Shibu Vijayan, Sarin Sanjay, Singh Chadha Sarabjit, Heitkamp Petra, Das Jishnu, Rao Raghuram, Pai Madhukar

机构信息

Clinton Health Access Initiative (CHAI), India.

McGill International TB Centre, Montreal, Canada.

出版信息

J Clin Tuberc Other Mycobact Dis. 2022 Aug;28:100327. doi: 10.1016/j.jctube.2022.100327. Epub 2022 Jul 19.

DOI:10.1016/j.jctube.2022.100327
PMID:35874450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9295336/
Abstract

BACKGROUND

India's dominant private healthcare sector is the destination for 60-85% of initial tuberculosis care-seeking. The COVID-19 pandemic in India drastically affected TB case notifications in the first half of 2020. In this survey, we assessed the impact of the first wave of COVID-19 in India on private providers, and changes they adopted in their practice due to the pandemic.

METHODS

The Joint Effort for Elimination of TB (JEET) is a nationwide Global Fund project implemented across 406 districts in 23 states to extend quality TB services to patients seeking care in private sector. We conducted a rapid survey of 11% (2,750) of active providers engaged under JEET's intense Patient Provider Support Agency (PPSA) model across 15 Indian states in Q1 (February-March) of 2021. Providers were contacted in person or telephonically, and consenting participants were interviewed using a web-based survey tool. Responses from participants were elicited on their practice before COVID-19, during the 2020 lockdowns (March-April 2020) and currently (Q1 2021). Data were adjusted for survey design and non-response, and results were summarised using descriptive statistics and logistic regression.

RESULTS

Of the 2,750 providers sampled, 2,011 consented and were surveyed (73 % response). Nearly 50 % were between 30 and 45 years of age, and 51 % were from Uttar Pradesh, Maharashtra and Gujarat. Seventy percent of providers reported reduced daily out-patient numbers in Q1 2021 compared to pre-COVID times. During the lockdown, 898 (40 %) of providers said their facilities were closed, while 323 (11 %) offered limited services including teleconsultation. In Q1 2021, 88 % of provider facilities were fully open, with 10 % providing adjusted services, and 4 % using teleconsultation. Only 2 % remained completely closed. Majority of the providers (92 %) reported not experiencing any delays in TB testing in Q1 2021 compared to pre-COVID times. Only 6 % reported raising costs at their clinic, mostly to cover personal protective equipment (PPE) and other infection control measures, although 60-90 % implemented various infection control measures. Thirty-three percent of TB providers were ordering COVID-19 testing, in addition to TB testing.To adapt, 82% of survey providers implemented social distancing and increased timing between appointments and 83% started conducting temperature checks, with variation by state and provider type, while 89% adopted additional sanitation measures in their facilities. Furthermore, 62% of providers started using PPE, and 13% made physical changes (air filters, isolation of patient areas) to their clinic to prevent infection. Seventy percent of providers stated that infection control measures could decrease TB transmission.

CONCLUSION

Although COVID-19 restrictions resulted in significant declines in patient turn-out at private facilities, our analysis showed that most providers were open and costs for TB care remained mostly the same in Q1 2021. As result of the COVID-19 pandemic, several positive strategies have been adapted by the private sector TB care providers. Since the subsequent COVID-19 waves were more severe or widespread, additional work is needed to assess the impact of the pandemic on the private health sector.

摘要

背景

印度占主导地位的私立医疗保健部门是60%-85%的肺结核初诊患者寻求治疗的目的地。印度的新冠疫情在2020年上半年严重影响了肺结核病例通报。在本次调查中,我们评估了印度第一波新冠疫情对私立医疗服务提供者的影响,以及他们因疫情而在业务中采取的变化。

方法

消除结核病联合行动(JEET)是一个由全球基金资助的全国性项目,在23个邦的406个区实施,旨在为在私立部门寻求治疗的患者提供优质的结核病服务。2021年第一季度(2月至3月),我们对印度15个邦参与JEET强化患者-医疗服务提供者支持机构(PPSA)模式的11%(2750名)在职医疗服务提供者进行了快速调查。通过亲自上门或电话联系医疗服务提供者,对同意参与的受访者使用基于网络的调查工具进行访谈。询问受访者在新冠疫情之前、2020年封锁期间(2020年3月至4月)和当前(2021年第一季度)的业务情况。对数据进行了调查设计和无回应方面的调整,并使用描述性统计和逻辑回归对结果进行了总结。

结果

在抽取的2750名医疗服务提供者中,2011名同意参与并接受了调查(回应率73%)。近50%的受访者年龄在30至45岁之间,51%来自北方邦、马哈拉施特拉邦和古吉拉特邦。70%的医疗服务提供者报告称,2021年第一季度的每日门诊量比新冠疫情之前有所减少。在封锁期间,898名(40%)医疗服务提供者表示他们的机构关闭,而323名(11%)提供包括远程会诊在内的有限服务。在2021年第一季度,88%的医疗服务提供者机构完全开放,10%提供调整后的服务,4%使用远程会诊。只有2%的机构仍然完全关闭。大多数医疗服务提供者(92%)报告称,2021年第一季度与新冠疫情之前相比,肺结核检测没有出现任何延误。只有6%的人报告称其诊所提高了费用,主要是为了支付个人防护装备(PPE)和其他感染控制措施的费用,尽管60%-90%的机构实施了各种感染控制措施。33%的结核病医疗服务提供者除了进行结核病检测外,还在进行新冠病毒检测。为了适应疫情,82%的接受调查的医疗服务提供者实施了社交距离措施并增加了预约间隔时间,83%开始进行体温检测,不同邦和医疗服务提供者类型存在差异,同时89%的机构在其场所采取了额外的卫生措施。此外,62%的医疗服务提供者开始使用个人防护装备,13%对其诊所进行了物理改造(安装空气过滤器、隔离患者区域)以预防感染。70%的医疗服务提供者表示感染控制措施可以减少结核病传播。

结论

尽管新冠疫情限制措施导致私立医疗机构的患者就诊量大幅下降,但我们的分析表明,大多数医疗服务提供者机构仍然开放,2021年第一季度结核病治疗费用基本保持不变。由于新冠疫情,私立部门的结核病医疗服务提供者采取了一些积极的策略。由于后续的新冠疫情浪潮更为严重或广泛传播,需要开展更多工作来评估疫情对私立医疗部门的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/48e62430a601/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/2970bd194f63/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/e4cc8942034a/gr2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/fb1101a8375e/gr2b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/402129f41304/gr2c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/2689a03b377f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/5e6fc1c4efaa/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/117f10b57e70/gr4b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/d07838dfc261/gr5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/d667b948028b/gr5b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/48e62430a601/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/2970bd194f63/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/e4cc8942034a/gr2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/fb1101a8375e/gr2b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/402129f41304/gr2c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/2689a03b377f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/5e6fc1c4efaa/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/117f10b57e70/gr4b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/d07838dfc261/gr5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/d667b948028b/gr5b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b7/9340511/48e62430a601/gr6.jpg

相似文献

1
Adaptations to the first wave of the COVID-19 pandemic by private sector tuberculosis care providers in India.印度私营部门结核病护理提供者对新冠疫情第一波的适应情况。
J Clin Tuberc Other Mycobact Dis. 2022 Aug;28:100327. doi: 10.1016/j.jctube.2022.100327. Epub 2022 Jul 19.
2
Tuberculosis service disruptions and adaptations during the first year of the COVID-19 pandemic in the private health sector of two urban settings in Nigeria-A mixed methods study.尼日利亚两个城市地区私营卫生部门在新冠疫情第一年期间的结核病服务中断与调整——一项混合方法研究
PLOS Glob Public Health. 2023 Mar 24;3(3):e0001618. doi: 10.1371/journal.pgph.0001618. eCollection 2023.
3
Health and tuberculosis systems resilience, the role of the private sector and pandemic preparedness: insights from a cross-country qualitative study with policy-makers in India, Indonesia and Nigeria.卫生与结核病系统的韧性、私营部门的作用及大流行防范:来自对印度、印度尼西亚和尼日利亚政策制定者的跨国定性研究的见解
BMJ Glob Health. 2025 Jan 20;10(1):e016180. doi: 10.1136/bmjgh-2024-016180.
4
Variations in the quality of tuberculosis care in urban India: A cross-sectional, standardized patient study in two cities.印度城市结核病护理质量的差异:两个城市的横断面标准化患者研究。
PLoS Med. 2018 Sep 25;15(9):e1002653. doi: 10.1371/journal.pmed.1002653. eCollection 2018 Sep.
5
Individual journeys to tuberculosis care in Nigeria's private sector during the COVID-19 pandemic.尼日利亚私营部门在新冠疫情期间结核病治疗的个人之旅。
BMJ Glob Health. 2024 Jan 9;9(1):e013124. doi: 10.1136/bmjgh-2023-013124.
6
Navigating the Pandemic: An Exploration of Medical Practitioners' Preparedness, Concerns, Adaptations, and Practices During the COVID-19 Epidemic in India.应对大流行:印度新冠疫情期间医疗从业者的准备情况、担忧、适应措施及实践探索
Cureus. 2023 Nov 12;15(11):e48677. doi: 10.7759/cureus.48677. eCollection 2023 Nov.
7
COVID-19 impact on health service- and TB-related practices among private providers in Indonesia.2019冠状病毒病对印度尼西亚私立医疗机构中与卫生服务及结核病相关业务的影响。
Public Health Action. 2023 Jun 21;13(2):37-42. doi: 10.5588/pha.23.0056.
8
COVID-19 policies and tuberculosis services in private health sectors of India, Indonesia, and Nigeria.印度、印度尼西亚和尼日利亚私立医疗部门的新冠疫情政策与结核病服务
J Clin Tuberc Other Mycobact Dis. 2024 Dec 2;38:100503. doi: 10.1016/j.jctube.2024.100503. eCollection 2025 Feb.
9
"Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.“在 Xpert 之前,我只有自己的专业知识”:一项在印度 4 个城市的儿科医生中评估 Xpert 技术应用和效果的定性研究。
PLoS One. 2018 Mar 16;13(3):e0193656. doi: 10.1371/journal.pone.0193656. eCollection 2018.
10
Operational priorities for engaging with India's private healthcare sector for the control of tuberculosis: a modelling study.与印度私营医疗保健部门合作控制结核病的运作重点:建模研究。
BMJ Open. 2024 Mar 19;14(3):e069304. doi: 10.1136/bmjopen-2022-069304.

引用本文的文献

1
Health and tuberculosis systems resilience, the role of the private sector and pandemic preparedness: insights from a cross-country qualitative study with policy-makers in India, Indonesia and Nigeria.卫生与结核病系统的韧性、私营部门的作用及大流行防范:来自对印度、印度尼西亚和尼日利亚政策制定者的跨国定性研究的见解
BMJ Glob Health. 2025 Jan 20;10(1):e016180. doi: 10.1136/bmjgh-2024-016180.
2
COVID-19 policies and tuberculosis services in private health sectors of India, Indonesia, and Nigeria.印度、印度尼西亚和尼日利亚私立医疗部门的新冠疫情政策与结核病服务
J Clin Tuberc Other Mycobact Dis. 2024 Dec 2;38:100503. doi: 10.1016/j.jctube.2024.100503. eCollection 2025 Feb.
3

本文引用的文献

1
Estimates of pandemic excess mortality in India based on civil registration data.基于民事登记数据对印度大流行期间超额死亡率的估计。
PLOS Glob Public Health. 2022 Dec 9;2(12):e0000803. doi: 10.1371/journal.pgph.0000803. eCollection 2022.
2
TB positive cases go up in ongoing COVID-19 pandemic despite lower testing of TB: An observational study from a hospital from Northern India.尽管结核病检测减少,但在持续的 COVID-19 大流行中结核病阳性病例仍在增加:来自印度北部一家医院的观察性研究。
Indian J Tuberc. 2022 Apr;69(2):157-160. doi: 10.1016/j.ijtb.2021.04.014. Epub 2021 May 5.
3
Diseases and Disparities: The Impact of COVID-19 Disruptions on Sexual and Reproductive Health Services Among the HIV Community in India.
The shifting landscape of private healthcare providers before and during the COVID-19 pandemic: Lessons to strengthen the private sectors engagement for future pandemic and tuberculosis care.
新冠疫情之前及期间私立医疗服务提供者的格局变化:加强私立部门参与未来疫情及结核病防治的经验教训
PLOS Glob Public Health. 2024 Oct 3;4(10):e0003112. doi: 10.1371/journal.pgph.0003112. eCollection 2024.
4
Case fatality among people with drug-susceptible TB enrolled in a private health sector TB treatment support program in Bihar, India during the first year of the COVID-19 pandemic.在印度比哈尔邦一个私营卫生部门结核病治疗支持项目中登记的药物敏感型结核病患者在2019年冠状病毒病大流行第一年的病死率。
PLOS Glob Public Health. 2024 Sep 12;4(9):e0003277. doi: 10.1371/journal.pgph.0003277. eCollection 2024.
5
The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020-2023.2020 - 2023年新冠疫情对结核病的全球影响:一项主题范围综述
PLOS Glob Public Health. 2024 Jul 3;4(7):e0003043. doi: 10.1371/journal.pgph.0003043. eCollection 2024.
6
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.全球、区域和国家在实现世卫组织 2020 年结核病战略里程碑方面的年龄特定进展:2021 年全球疾病负担研究的系统分析。
Lancet Infect Dis. 2024 Jul;24(7):698-725. doi: 10.1016/S1473-3099(24)00007-0. Epub 2024 Mar 19.
7
COVID-19 impact on health service- and TB-related practices among private providers in Indonesia.2019冠状病毒病对印度尼西亚私立医疗机构中与卫生服务及结核病相关业务的影响。
Public Health Action. 2023 Jun 21;13(2):37-42. doi: 10.5588/pha.23.0056.
8
Tuberculosis service disruptions and adaptations during the first year of the COVID-19 pandemic in the private health sector of two urban settings in Nigeria-A mixed methods study.尼日利亚两个城市地区私营卫生部门在新冠疫情第一年期间的结核病服务中断与调整——一项混合方法研究
PLOS Glob Public Health. 2023 Mar 24;3(3):e0001618. doi: 10.1371/journal.pgph.0001618. eCollection 2023.
9
Implementation of a tuberculosis elimination project, India 2018-2019.2018-2019 年印度实施结核病消除项目。
Bull World Health Organ. 2023 Mar 1;101(3):179-190. doi: 10.2471/BLT.22.288277. Epub 2023 Jan 18.
疾病与差异:COVID-19 疫情对印度 HIV 群体中性与生殖健康服务的影响。
Arch Sex Behav. 2022 Jan;51(1):315-329. doi: 10.1007/s10508-021-02211-5. Epub 2022 Jan 20.
4
The second wave of COVID-19: effect on Indian health care system.新冠疫情第二波:对印度医疗体系的影响
Horm Mol Biol Clin Investig. 2021 Jul 30;42(4):343-344. doi: 10.1515/hmbci-2021-0040.
5
The aftermath of COVID-19 pandemic on the diagnosis of TB at a tertiary care hospital in India.COVID-19 大流行对印度一家三级保健医院结核病诊断的影响。
J Infect Public Health. 2021 Aug;14(8):1095-1098. doi: 10.1016/j.jiph.2021.07.001. Epub 2021 Jul 8.
6
Informal collectives and access to healthcare during India's COVID-19 second wave crisis.印度新冠疫情第二波危机期间的非正式群体与医疗保健获取情况
BMJ Glob Health. 2021 Jul;6(7). doi: 10.1136/bmjgh-2021-006731.
7
Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: A community perspective.COVID-19期间基于医疗机构的结核病直接观察治疗(DOT):社区视角
J Clin Tuberc Other Mycobact Dis. 2021 Jun 25;24:100248. doi: 10.1016/j.jctube.2021.100248. eCollection 2021 Aug.
8
Impact of COVID-19 on cancer care in India: a cohort study.新型冠状病毒肺炎对印度癌症治疗的影响:一项队列研究。
Lancet Oncol. 2021 Jul;22(7):970-976. doi: 10.1016/S1470-2045(21)00240-0. Epub 2021 May 27.
9
The impact of COVID-19 on TB: a review of the data.COVID-19 对结核病的影响:数据回顾。
Int J Tuberc Lung Dis. 2021 Jun 1;25(6):436-446. doi: 10.5588/ijtld.21.0148.
10
Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study.《COVID-19 大流行对印度慢性病患者的健康、心理社会和经济影响:一项混合方法研究》
BMC Public Health. 2021 Apr 8;21(1):685. doi: 10.1186/s12889-021-10708-w.